Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Federal Trade Commission
Argus Health

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088387

« Back to Dashboard

NDA 088387 describes SCANDONEST PLAIN, which is a drug marketed by Deproco and is included in one NDA. It is available from eleven suppliers. Additional details are available on the SCANDONEST PLAIN profile page.

The generic ingredient in SCANDONEST PLAIN is mepivacaine hydrochloride. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the mepivacaine hydrochloride profile page.

Summary for 088387

Formulation / Manufacturing:see details

Pharmacology for NDA: 088387

Physiological EffectLocal Anesthesia

Medical Subject Heading (MeSH) Categories for 088387

Suppliers and Packaging for NDA: 088387

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SCANDONEST PLAIN mepivacaine hydrochloride INJECTABLE;INJECTION 088387 ANDA Henry Schein Inc. 0404-6730 0404-6730-05 5 BLISTER PACK in 1 CARTON (0404-6730-05) > 10 CARTRIDGE in 1 BLISTER PACK > 1.7 mL in 1 CARTRIDGE
SCANDONEST PLAIN mepivacaine hydrochloride INJECTABLE;INJECTION 088387 ANDA Henry Schein Inc. 0404-6730 0404-6730-30 30 SYRINGE in 1 CARTRIDGE (0404-6730-30) > 1 CARTRIDGE in 1 SYRINGE > 1.7 mL in 1 CARTRIDGE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength3%
Approval Date:Oct 10, 1984TE:APRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Argus Health
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: